FMS European Long-Term Study

PHASE3CompletedINTERVENTIONAL
Enrollment

490

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
Fibromyalgia Syndrome
Interventions
DRUG

milnacipran

hard capsule

DRUG

Placebo

hard capsule

Trial Locations (10)

2609

Center For Clinical Studies, Lillehamer

20157

Ospedale Luigi Sacco, Milan

43137

Gottfriesclinic Ab, Mölndal

70100

Kuopion Oma Laakari Oy, Kuopio

530 02

Rheumatology Ambulance, Pardubice

Unknown

Hopital Hotel Dieu, Paris

D50931

KKSK KLINIKUM DER UNIVERSITAET ZU KOELN - Anaesthesiology and Intensive Care, Cologne

1349-019

Hospital Egas Moniz, Lisbon

020475

Dr I CANTACUZINO CLINICAL HOSPITAL, Bucharest

08024

Hospital de La Esperanza, Barcelona

All Listed Sponsors
lead

Pierre Fabre Medicament

INDUSTRY

NCT00757731 - FMS European Long-Term Study | Biotech Hunter | Biotech Hunter